Moors & Cabot, Inc. Ark Genomic Revolution ETF (De Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Moors & Cabot, Inc. holds 7,961 shares of ARKG stock, worth $196,318. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,961

Previous 8,861 10.16%

Holding current value

$196,318

Previous $208,000 2.4%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$22.89 - $27.41 $20,601 - $24,669	-900 Reduced 10.16%	7,961 $203,000
Q2 2024 Aug 09, 2024	SELL	$23.01 - $28.35 $16,107 - $19,845	-700 Reduced 7.32%	8,861 $208,000
Q4 2023 Feb 14, 2024	SELL	$22.24 - $34.25 $34,472 - $53,087	-1,550 Reduced 13.95%	9,561 $313,000
Q3 2023 Nov 07, 2023	SELL	$27.6 - $38.18 $828 - $1,145	-30 Reduced 0.27%	11,111 $309,000
Q2 2023 Aug 09, 2023	SELL	$28.26 - $35.21 $565 - $704	-20 Reduced 0.18%	11,141 $379,000
Q1 2023 May 04, 2023	SELL	$27.46 - $36.49 $10,984 - $14,596	-400 Reduced 3.46%	11,161 $335,000
Q4 2022 Feb 09, 2023	SELL	$27.08 - $36.23 $183,494 - $245,494	-6,776 Reduced 36.95%	11,561 $326,000
Q4 2022 Feb 06, 2023	BUY	$27.08 - $36.23 $160,476 - $214,698	5,926 Added 47.75%	18,337 $517,000
Q3 2022 Nov 07, 2022	SELL	$31.57 - $42.39 $76,115 - $102,202	-2,411 Reduced 16.27%	12,411 $408,000
Q2 2022 Aug 08, 2022	SELL	$27.2 - $48.94 $38,433 - $69,152	-1,413 Reduced 8.7%	14,822 $467,000
Q1 2022 May 13, 2022	SELL	$38.15 - $63.26 $80,191 - $132,972	-2,102 Reduced 11.46%	16,235 $746,000
Q4 2021 Feb 14, 2022	SELL	$58.39 - $78.64 $220,830 - $297,416	-3,782 Reduced 17.1%	18,337 $1.12 Million
Q3 2021 Dec 08, 2021	BUY	$73.87 - $92.86 $1.63 Million - $2.05 Million	22,119 New	22,119 $1.65 Million
Q3 2021 Nov 05, 2021	SELL	$73.87 - $92.86 $1.63 Million - $2.05 Million	-22,124 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$73.64 - $93.1 $152,361 - $192,623	2,069 Added 10.32%	22,124 $2.05 Million
Q1 2021 May 12, 2021	BUY	$81.74 - $112.47 $347,395 - $477,997	4,250 Added 26.89%	20,055 $1.78 Million
Q4 2020 Feb 11, 2021	BUY	$63.39 - $105.53 $347,820 - $579,043	5,487 Added 53.18%	15,805 $1.48 Million
Q3 2020 Nov 09, 2020	SELL	$53.19 - $64.24 $154,995 - $187,195	-2,914 Reduced 22.02%	10,318 $657,000
Q2 2020 Aug 13, 2020	BUY	$29.13 - $53.08 $118,792 - $216,460	4,078 Added 44.55%	13,232 $690,000
Q4 2019 Jan 28, 2020	BUY	$27.95 - $36.43 $22,136 - $28,852	792 Added 9.47%	9,154 $308,000
Q3 2019 Oct 22, 2019	BUY	$29.35 - $35.25 $14,675 - $17,625	500 Added 6.36%	8,362 $248,000
Q2 2019 Jul 18, 2019	BUY	$29.12 - $34.56 $228,941 - $271,710	7,862 New	7,862 $270,000

Others Institutions Holding ARKG

# of Institutions

287

Shares Held

24.5M

Call Options Held

3.02M

Put Options Held

2.65M

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account